Research programme: aspirin/protein pump inhibitors - Old API Wind-down
Latest Information Update: 12 Feb 2019
At a glance
- Originator POZEN
- Developer Old API Wind-down Ltd
- Class 2 pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Non-opioid analgesics; Salicylic acids; Small molecules
- Mechanism of Action Cyclooxygenase inhibitors; Nitric oxide stimulants; Platelet aggregation inhibitors; Proton pump inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Cancer; Cardiovascular disorders; NSAID-induced ulcer
Most Recent Events
- 06 Feb 2019 Aralez Pharmaceuticals is now called Old API Wind-down
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cancer(Prevention) in USA (PO)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cardiovascular-disorders(Prevention) in USA (PO)